These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 26783563)
1. Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides. Huang Y; Cheng Q; Jin X; Ji JL; Guo S; Zheng S; Wang X; Cao H; Gao S; Liang XJ; Du Q; Liang Z Biomater Sci; 2016 Mar; 4(3):494-510. PubMed ID: 26783563 [TBL] [Abstract][Full Text] [Related]
2. Systemic Administration of siRNA via cRGD-containing Peptide. Huang Y; Wang X; Huang W; Cheng Q; Zheng S; Guo S; Cao H; Liang XJ; Du Q; Liang Z Sci Rep; 2015 Aug; 5():12458. PubMed ID: 26300278 [TBL] [Abstract][Full Text] [Related]
3. Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. Curnis F; Cattaneo A; Longhi R; Sacchi A; Gasparri AM; Pastorino F; Di Matteo P; Traversari C; Bachi A; Ponzoni M; Rizzardi GP; Corti A J Biol Chem; 2010 Mar; 285(12):9114-23. PubMed ID: 20064928 [TBL] [Abstract][Full Text] [Related]
4. An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells. Zhang Z; Hou L; Feng L; Huang S; Luo M; Shao S; Zhang X; Gu S; Zhao X Tumour Biol; 2015 Sep; 36(10):8167-75. PubMed ID: 25990455 [TBL] [Abstract][Full Text] [Related]
5. NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences. Soudy R; Ahmed S; Kaur K ACS Comb Sci; 2012 Nov; 14(11):590-9. PubMed ID: 23030271 [TBL] [Abstract][Full Text] [Related]
6. MicroPET imaging of CD13 expression using a (64)Cu-labeled dimeric NGR peptide based on sarcophagine cage. Li G; Wang X; Zong S; Wang J; Conti PS; Chen K Mol Pharm; 2014 Nov; 11(11):3938-46. PubMed ID: 25054774 [TBL] [Abstract][Full Text] [Related]
7. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. Chen Y; Wu JJ; Huang L Mol Ther; 2010 Apr; 18(4):828-34. PubMed ID: 20068551 [TBL] [Abstract][Full Text] [Related]
9. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034 [TBL] [Abstract][Full Text] [Related]
10. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Curnis F; Arrigoni G; Sacchi A; Fischetti L; Arap W; Pasqualini R; Corti A Cancer Res; 2002 Feb; 62(3):867-74. PubMed ID: 11830545 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134 [TBL] [Abstract][Full Text] [Related]
12. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394 [TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET. Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells. Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440 [TBL] [Abstract][Full Text] [Related]
15. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands. Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614 [TBL] [Abstract][Full Text] [Related]
17. (99m)Tc-labeled monomeric and dimeric NGR peptides for SPECT imaging of CD13 receptor in tumor-bearing mice. Ma W; Kang F; Wang Z; Yang W; Li G; Ma X; Li G; Chen K; Zhang Y; Wang J Amino Acids; 2013 May; 44(5):1337-45. PubMed ID: 23456486 [TBL] [Abstract][Full Text] [Related]
18. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318 [TBL] [Abstract][Full Text] [Related]
20. Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy. Liu L; Liu X; Xu Q; Wu P; Zuo X; Zhang J; Deng H; Wu Z; Ji A Int J Nanomedicine; 2014; 9():3509-26. PubMed ID: 25114522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]